+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cushing's Syndrome Diagnostics and Treatment - Global Market Trajectory & Analytics

  • ID: 5139758
  • Report
  • April 2021
  • Region: Global
  • 128 Pages
  • Global Industry Analysts, Inc
Global Cushing's Syndrome Diagnostics and Treatment Market to Reach $461.4 Million by 2027

Amid the COVID-19 crisis, the global market for Cushing's Syndrome Diagnostics and Treatment estimated at US$289.2 Million in the year 2020, is projected to reach a revised size of US$461.4 Million by 2027, growing at a CAGR of 6.9% over the period 2020-2027. Diagnostics, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$187.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Treatment segment is readjusted to a revised 6.8% CAGR for the next 7-year period.



The U.S. Market is Estimated at $85.4 Million, While China is Forecast to Grow at 6.5% CAGR

The Cushing's Syndrome Diagnostics and Treatment market in the U.S. is estimated at US$85.4 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$80.8 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Select Competitors (Total 44 Featured):
  • Corcept Therapeutics, Inc.
  • HRA Pharma
  • Novartis AG
  • Orphagen Pharmaceuticals, Inc.
  • Strongbridge Biopharma
Frequently Asked Questions about the Global Market for Cushing's Syndrome Diagnostics and Treatment

What is the estimated value of the Global Market for Cushing's Syndrome Diagnostics and Treatment?

The Global Market for Cushing's Syndrome Diagnostics and Treatment was estimated to be valued at $289.2 Million in 2020.

What is the growth rate of the Global Market for Cushing's Syndrome Diagnostics and Treatment?

The growth rate of the Global Market for Cushing's Syndrome Diagnostics and Treatment is 6.9%, with an estimated value of $461.4 Million by 2027.

What is the forecasted size of the Global Market for Cushing's Syndrome Diagnostics and Treatment?

The Global Market for Cushing's Syndrome Diagnostics and Treatment is estimated to be worth $461.4 Million by 2027.
Note: Product cover images may vary from those shown

I. METHODOLOGY
II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Cushing's Syndrome Diagnostics and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS
  • Table 10: USA Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 11: USA Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: USA 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 13: Canada Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 14: Canada Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: Canada 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 16: Japan Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 17: Japan Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: Japan 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 19: China Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: China Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: China 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 22: Europe Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 23: Europe Historic Review for Cushing's Syndrome Diagnostics and Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: Europe 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 25: Europe Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: Europe Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: Europe 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 28: France Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 29: France Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: France 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 31: Germany Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Germany Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: Germany 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 34: Italy Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: Italy Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: Italy 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 37: UK Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: UK Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 39: UK 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 40: Rest of Europe Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 41: Rest of Europe Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 42: Rest of Europe 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 43: Asia-Pacific Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: Asia-Pacific Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 45: Asia-Pacific 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027
  • Table 46: Rest of World Current & Future Analysis for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: Rest of World Historic Review for Cushing's Syndrome Diagnostics and Treatment by Segment - Diagnostics and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 48: Rest of World 15-Year Perspective for Cushing's Syndrome Diagnostics and Treatment by Segment - Percentage Breakdown of Value Sales for Diagnostics and Treatment for the Years 2012, 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown